| 5.09 0.113 (2.27%) | 03-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.53 | 1-year : | 7.34 |
| Resists | First : | 5.59 | Second : | 6.28 |
| Pivot price | 5.05  |
|||
| Supports | First : | 4.46 | Second : | 3.71 |
| MAs | MA(5) : | 4.96  |
MA(20) : | 5.04 |
| MA(100) : | 5.04 |
MA(250) : | 5.96 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 29.8 |
D(3) : | 28.6 |
| RSI | RSI(14): 52.9 |
|||
| 52-week | High : | 7.5 | Low : | 4.46 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AUNA ] has closed below upper band by 43.9%. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.1 - 5.13 | 5.13 - 5.15 |
| Low: | 4.77 - 4.8 | 4.8 - 4.83 |
| Close: | 5.04 - 5.09 | 5.09 - 5.13 |
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Sat, 14 Mar 2026
Auna S.A. (NYSE:AUNA) Short Interest Update - MarketBeat
Fri, 13 Mar 2026
Auna (AUNA) Q4 Loss And 2.2% Margin Test Bullish Earnings Growth Narrative - Sahm
Thu, 12 Mar 2026
Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Thu, 12 Mar 2026
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks - Yahoo Finance
Wed, 11 Mar 2026
Is Auna S.A. (AUNA) Shares Surpassing Other Medical Stocks This Year? - Bitget
Wed, 11 Mar 2026
Auna S.A. 2025 Q4 - Results - Earnings Call Presentation (NYSE:AUNA) 2026-03-11 - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 30 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 42.5 (%) |
| Shares Short | 312 (K) |
| Shares Short P.Month | 288 (K) |
| EPS | 0.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.42 |
| Profit Margin | 4.3 % |
| Operating Margin | 14.8 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 11.4 % |
| Qtrly Rev. Growth | -0.9 % |
| Gross Profit (p.s.) | 55.48 |
| Sales Per Share | 143.52 |
| EBITDA (p.s.) | 27.73 |
| Qtrly Earnings Growth | -51 % |
| Operating Cash Flow | 633 (M) |
| Levered Free Cash Flow | 137 (M) |
| PE Ratio | 5.24 |
| PEG Ratio | 0 |
| Price to Book value | 0.79 |
| Price to Sales | 0.03 |
| Price to Cash Flow | 0.24 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|